OPKO Health, Inc. (OPK)
1.53
-0.08
(-4.97%)
USD |
NASDAQ |
Oct 16, 16:00
1.55
+0.02
(+1.31%)
After-Hours: 20:00
OPKO Health Research and Development Expense (Annual) : 124.03M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 124.03M |
| December 31, 2024 | 105.21M |
| December 31, 2023 | 89.59M |
| December 31, 2022 | 73.89M |
| December 31, 2021 | 76.85M |
| December 31, 2020 | 75.32M |
| December 31, 2019 | 117.87M |
| December 31, 2018 | 125.59M |
| December 31, 2017 | 126.44M |
| December 31, 2016 | 113.87M |
| December 31, 2015 | 101.80M |
| December 31, 2014 | 85.92M |
| December 31, 2013 | 52.96M |
| December 31, 2012 | 19.52M |
| Date | Value |
|---|---|
| December 31, 2011 | 11.35M |
| December 31, 2010 | 7.908M |
| December 31, 2009 | 12.88M |
| December 31, 2008 | 21.56M |
| December 31, 2007 | 10.85M |
| December 31, 2006 | 0.00 |
| December 31, 2005 | 0.00 |
| December 31, 2004 | |
| December 31, 2003 | |
| December 31, 2002 | |
| December 31, 2001 | |
| December 31, 2000 | |
| December 31, 1999 | 2.332M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median